Calvin Sandra
SEC insider (Form 3/4/5 filer). CIK 0001882909. SVP, CHIEF ACCOUNTING OFFICER at Travere Therapeutics, Inc. (TVTX). 36 reported Form 4/5 transactions since Sep 2024; latest on Sep 15, 2026. Located in SAN DIEGO, CA.
Companies Calvin Sandra has filed insider reports for
- Travere Therapeutics, Inc. (TVTX): Officer, SVP, CHIEF ACCOUNTING OFFICER
Calvin Sandra
CIK: 0001882909
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Travere Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (36 total)
- Sep 15, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect2.5K shares at avg. $27.50$69K - Sep 15, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect1.6K shares at avg. $20.46$33K - Sep 15, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect800 shares at avg. $62.85$50K - Sep 15, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect300 shares at avg. $63.66$19K - Sep 15, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect4.3K shares at avg. $62.13$266K - Sep 15, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect1.3K shares at avg. $22.40$28K - Apr 14, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect22K shares at avg. $41.07$903K - Apr 14, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect6.5K shares at avg. $20.46$133K - Apr 14, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect6.3K shares at avg. $8.93$56K - Apr 14, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect2.5K shares at avg. $22.40$56K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 2,500 | $27.50 | $68,750 | Direct |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 1,625 | $20.46 | $33,248 | Direct |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 800 | $62.85 | $50,278 | Direct |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 300 | $63.66 | $19,099 | Direct |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 4,275 | $62.13 | $265,627 | Direct |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 1,250 | $22.40 | $28,000 | Direct |
| Apr 14, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 21,977 | $41.07 | $902,595 | Direct |
| Apr 14, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 6,500 | $20.46 | $132,990 | Direct |
| Apr 14, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 6,250 | $8.93 | $55,813 | Direct |
| Apr 14, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 2,500 | $22.40 | $56,000 | Direct |
1-10 of 36 transactions